Quest Diagnostics Inc posted third-quarter adjusted earnings per share of $2.30, beating the consensus of $2.26. Sales increased 8.5% year-over-year to $2.49 billion, beating the consensus of $2.42 billion. Quest Diagnostics ( DGX ) saw total revenue growth of 8.5%, including 4.2% organic growth, said Quest Diagnostics CEO Jim Davis. “Our performance was driven by new customer wins and expanded business with physicians...

11:17 AM EDT, 10/22/2024 (MT Newswires) -- Price: 720.42, Change: +6.32, Percent Change: +0.89 ...

RIO DE JANEIRO/BRASILIA (Reuters) - An agreement by Vale, BHP and their joint venture Samarco to pay 170 billion reais ($29.85 billion) in compensation for a deadly dam collapse in Brazil could end more than a hundred lawsuits against the mining companies in the South American country and possibly limit legal action abroad, three sources close to the matter said....

11:06 AM EDT, 10/22/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) was last seen up 3.6% after the company on Tuesday released new positive data in its Phase 2 metastatic breast cancer (MBC) study. In the study, patients treated with the same Bria-IMT regimen formulation being used in the ongoing Phase 3 pivotal trial experienced a one-year survival rate...